Search global stocks & ETFs...Ctrl K
Learn Mode
Royalty Pharma PLCRPRX
$53.70
-$0.51 (-0.941%)
$53.51
-$0.20 (-0.363%)
RPRX
Stock Profile
08-04
Recommended Metric
Score Card
Explore Scores Tab
3.50
Good
Valuation Score
Key Score
3.00
Average
Management
2.00
Bad
Growth
1.00
Very Bad
Profitability
3.00
Average
Fin. Health
3.00
Average
Dividends
3.00
Average
Analyst
1.00
Very Bad
Insider Transactions
Explore Insider Tab ›Buy Transactions
Sell Transactions
Peers
Select stocks to compare
Price Targets & Ratings
View Analysis
1-year price targets, ending May 11, 2027
Current
$53.70
Baseline
High
$69.30
▲
29.05%
Avg
$58.38
▲
8.72%
Low
$46.46
▼
-13.48%
Analyst Ratings based on 16 Analysts
Strong Buy
531%
Buy
956%
Hold
213%
Sell
000%
Strong Sell
000%
Royalty Pharma Plc engages in the provision of drug development services. The company is headquartered in New York City, New York and currently employs 100 full-time employees. The company went IPO on 2020-06-16. The company collaborates with innovators from academic institutions, research hospitals and non-profits from small and mid-cap biotechnology companies to global pharmaceutical companies. The company funds innovation in the biopharmaceutical industry both directly and indirectly. Directly when it partners with companies to co-fund late-stage clinical trials and new product launches in exchange for future royalties. Indirectly when it acquires existing royalties from the original innovators. Its portfolio includes royalties on more than 35 commercial products, including Vertex’s Trikafta and Alyftrek, Johnson & Johnson’s Tremfya, GSK’s Trelegy, Roche’s Evrysdi, Servier’s Voranigo, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, and Gilead’s Trodelvy, among others, and 20 development-stage product candidates.Read More
Stock News
View All Updates
Royalty Pharma plc (RPRX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
1wSeekingAlpha
Dividend Champion, Contender, And Challenger Highlights: Week Of June 7
1wSeekingAlpha
Royalty Pharma plc (RPRX) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
4wSeekingAlpha
Royalty Pharma: Strong Execution, Expanding Pipeline And More Firepower Ahead
4wSeekingAlpha
Royalty Pharma plc (RPRX) Presents at Bank of America Global Healthcare Conference 2026 Transcript
5wSeekingAlpha
Transcript : Royalty Pharma plc Presents at Bank of America Global Healthcare Conference 2026, May-13-2026 10
5wFinnhub
Royalty Pharma : Q1 2026 Financial Results Call Transcript
5wFinnhub
Anaptys Announces First Quarter 2026 Financial Results and Provides Business Update
5wYahoo
Income Investors Should Know That Royalty Pharma plc (NASDAQ:RPRX) Goes Ex-Dividend Soon
5wYahoo
Why One Fund’s $4 Million Centerra Gold Exit Looks Like Profit-Taking Amid a 150% Rally
5wYahoo
Dividend Champion, Contender, And Challenger Highlights: Week Of May 10
5wSeekingAlpha
This Fund Cashed Out of Preformed Line Products Amid a 150% Stock Surge
5wYahoo
10% Of This Royalty Pharma Insider's Holdings Were Sold
5wYahoo
Royalty Pharma to present at upcoming investor conferences
5wYahoo
Citigroup Maintains Buy on Royalty Pharma, Raises Price Target to $66
5wBenzinga
JP Morgan Maintains Overweight on Royalty Pharma, Raises Price Target to $58
5wBenzinga
Royalty Pharma Q1 Earnings Call Highlights
6wYahoo
Royalty Pharma plc Q1 2026 Earnings Call Summary
6wYahoo
Earnings Scheduled For May 6, 2026
6wBenzinga
RPRX vs. AMGN: Which Stock Is the Better Value Option?
6wYahoo
Royalty Pharma PLC (RPRX) Hit a 52 Week High, Can the Run Continue?
6wYahoo
Royalty Pharma (RPRX) Q1 Earnings and Revenues Surpass Estimates
6wYahoo
Royalty Pharma (NASDAQ:RPRX) Beats Q1 Estimates and Raises Guidance, Fueling Strong Momentum
6wChartMill
Royalty Pharma plc (RPRX) Q1 2026 Earnings Call Transcript
6wSeekingAlpha
Royalty Pharma reports first quarter 2026 results
6wYahoo
Royalty Pharma plc Reports Earnings Results for the First Quarter Ended March 31, 2026
6wFinnhub
Royalty Pharma Reports Q1 2026 Results: Full Earnings Call Transcript
6wBenzinga
Transcript : Royalty Pharma plc, Q1 2026 Earnings Call, May 06, 2026
6wFinnhub
Royalty Pharma plc 2026 Q1 - Results - Earnings Call Presentation
6wSeekingAlpha
Royalty Pharma : Q1 2026 Financial Results Presentation
6wFinnhub
Royalty Pharma : Q1 2026 Press Release
6wFinnhub
Royalty Pharma: Q1 Earnings Snapshot
6wFinnhub
Royalty Pharma Q1 Adj. EPS $1.30 Beats $1.21 Estimate, Sales $631.000M Miss $1.235B Estimate
6wBenzinga
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
6wYahoo
Codexis (CDXS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
6wYahoo
Royalty Pharma (RPRX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
7wYahoo
A Look At Royalty Pharma (RPRX) Valuation After Its Recent Share Price Momentum
7wYahoo
Zymeworks Highlights Royalty-Fueled Pivot at Bloom Burton, Eyes Multibillion-Dollar Ziihera
7wYahoo
3 Unpopular Stocks We’re Skeptical Of
8wYahoo
Royalty Pharma Launches Global Translational Prize to Recognize Breakthrough Scientific Innovation
8wYahoo
Why Royalty Pharma Plc (RPRX) is One of the Most Undervalued Biotech Stocks to Buy Right Now
8wYahoo
Royalty Pharma plc Declares Dividend for the Second Quarter 2026, Payable on June 10, 2026
8wFinnhub
Royalty Pharma Declares Second Quarter 2026 Dividend
8wFinnhub
Royalty Pharma : Q1 2026 Pre-Quarterly Results Communication
9wFinnhub
Royalty Pharma to Announce First Quarter 2026 Financial Results on May 6, 2026
9wFinnhub
Royalty Pharma : 2025 Corporate Responsibility Report pdf
9wFinnhub
Revolution Medicines: PDAC Data Wows Wall Street - Jury's Out On Further Upside
9wSeekingAlpha
Morgan Stanley Maintains Overweight on Royalty Pharma, Raises Price Target to $63
9wBenzinga
Royalty Pharma Announces R&D Co-Funding Agreement With Johnson & Johnson For Total Of $500M In 2026 And 2027 To Advance Development Of JNJ-4804, Investigational Medicine For Autoimmune Diseases
11wBenzinga
Royalty Pharma PLC (NASDAQ:RPRX) Emerges as a Compelling Value Investment
11wChartMill
